The global burden of women's cancers: a grand challenge in global health

The Lancet

Volumn 389, Issue 10071, 2017, Pages 847-860

  Ginsburg, Ophira ^a,b   Bray, Freddie ^c   Coleman, Michel P ^d   Vanderpuye, Verna ^e   Eniu, Alexandru ^f   Kotha, S Rani ^g   Sarker, Malabika ^h   Huong, Tran Thanh ⁱ   Allemani, Claudia ^d   Dvaladze, Allison ^j   Gralow, Julie ^j   Yeates, Karen ^k   Taylor, Carolyn ^l   Oomman, Nandini ^m   Krishnan, Suneeta ^n,o   Sullivan, Richard ^p   Kombe, Dominista ^q   Blas, Magaly M ^r   Parham, Groesbeck ^s,t   Kassami, Natasha ^u   Conteh, Lesong ^u   more..

^a WOMEN S COLLEGE HOSPITAL   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KORLE BU TEACHING HOSPITAL   (Ghana)

^f Cancer Institute Ion Chiricuta Cluj Napoca   (Romania)

^g UNIVERSITY OF TORONTO   (Canada)

^h BRAC UNIVERSITY   (Bangladesh)

ⁱ HANOI MEDICAL UNIVERSITY   (Viet Nam)

^j UNIVERSITY OF WASHINGTON   (United States)

^k QUEEN S UNIVERSITY   (Canada)

^l Global Focus on Cancer   (United States)

^m Independent Global Health Specialist   (United States)

ⁿ Research Triangle Institute Global Pvt Limited   (India)

^o ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^p KING'S COLLEGE LONDON   (United Kingdom)

^q Ocean Road Cancer Centre ^*  (Tanzania)

^r UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^s UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^t UNIVERSITY OF ZAMBIA   (Zambia)

^u IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN DEVELOPMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SOCIETY; UTERINE CERVIX CANCER; WOMEN'S HEALTH; GLOBAL HEALTH; INCIDENCE; INCOME; POVERTY; SOCIAL CLASS;

FEMALE; GLOBAL HEALTH; HUMANS; INCIDENCE; INCOME; POVERTY; SOCIAL CLASS; WOMEN'S HEALTH;

EID: 85005916238     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(16)31392-7     Document Type: Review

References (111)

1. 1 Vos, T, Barber, RM, Bell, B, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386 (2015), 743–800.
2. 2 Soerjomataram, I, Lortet-Tieulent, J, Parkin, DM, et al. Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet 380 (2012), 1840–1850.
3. 3 Ferlay, J, Soerjomataram, I, Dikshit, R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
4. 4 Bruni, L, Diaz, M, Barrionueva-Rossas, L, et al. Global estimates of human papilloma virus vaccination by region and income level: a pooled analysis. Lancet Glob Health 4 (2016), e453–e463.
5. 5 Sullivan, R, Olusegun, IA, Anderson, BO, et al. Cancer surgery: delivering safe, affordable and timely cancer surgery. Lancet Oncol 16 (2015), 1193–1224.
6. 6 WHO. Essential Medicines Selection. Medicines for treatment of the following cancers – review – EML and EMLc EML. http://www.who.int/selection_medicines/committees/expert/20/applications/cancer/en/ (accessed Aug 15, 2016).
7. 7 Atun, R, Jaffray, DA, Barton, MB, et al. Expanding global access to radiotherapy. Lancet Oncol 16 (2015), 1153–1186.
8. 8 Worldwide Palliative Care Alliance and WHO. Global atlas of palliative care at the end of life. http://www.who.int/nmh/Global_Atlas_of_Palliative_Care.pdf, January, 2014 (accessed Aug 8, 2015).
9. 9 United Nations Population Fund (UNFPA). Maternal Health. http://www.unfpa.org/maternal-health (accessed Sept 1, 2016).
10. 10 Ginsburg, OM, Love, RR, Breast cancer: a neglected disease for the majority of affected women worldwide. Breast J 17 (2011), 289–295.
11. 11 Knaul, FM, Adami, HO, Adebamowo, C, Arreola-Ornelas, H, Berger, AJ, Bhadelia, A, The global cancer divide: an equity imperative. Knaul, FM, Gralow, R, Atun, R, Bhadelia, A, (eds.) Closing the cancer divide: an equity imperative, 2012, Harvard Global Equity Initiative, Cambridge, MA, 29–60.
12. 12 The Lancet. Breast cancer in developing countries. Lancet, 374, 2009, 1567.
13. 13 Whitehead, M, Whitehead, M, The concepts and principles of equity and health. Int J Health Serv 22 (1992), 429–445.
14. 14 Marmot, M, Friel, S, Bell, R, Houweling, TA, Taylor, S, Closing the gap in a generation: health equity through action on the social determinants of health. Lancet 372 (2008), 1661–1669.
15. 15 WHO. Global Action Plan for the Prevention and Control of Noncommunicable Diseases, 2013, World Health Organization http://www.who.int/nmh/events/ncd_action_plan/en/ (accessed April 11, 2016).
16. 16 Gelband, H, Jha, P, Sankaranarayanan, R, Gauvreau, Horton, S, Cancer. Jamison, DT, Gelband, H, Horton, S, Jha, P, Laximinarayan, R, Nugent, R, (eds.) Disease control priorities in developing countries, 3rd edn., 2015, World Bank, Washington, DC.
17. 17 Denny, L, de Sanjose, S, Mutebi, M, et al. Interventions to close the divide for women with breast and cervical cancer in low-, middle- and high-income countries. Lancet, 2016 published online Nov 1. http://dx.doi.org/10.1016/S0140-6736(16)31795-0.
18. 18 Collaborative Group on Hormonal Factors in Breast Cancer. Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 11 (2012), 1141–1151.
19. 19 Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96 973 women without the disease. Lancet 360 (2002), 187–195.
20. 20 Arnold, M, Pandeya, N, Byrnes, G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol 16 (2015), 36–46.
21. 21 Bosch, FX, Lorincz, A, Muñoz, N, Meijer, CJ, Shah, KV, The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55 (2002), 244–265.
22. 22 Denslow, SA, Rositch, AF, Firnhaber, C, Ting, J, Smith, JS, Incidence and progression of cervical lesions in women with HIV: a systematic global review. Int J STD AIDS 25 (2014), 163–177.
23. 23 Castellsagué, X, Muñoz, N, Chapter 3: cofactors in human papillomavirus carcinogenesis—role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31 (2003), 20–28.
24. 24 Allemani, C, Weir, HK, Carreira, H, et al., CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385 (2015), 977–1010.
25. 25 Sankaranarayanan, R, Swaminathan, R, Brenne, H, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11 (2010), 165–173.
26. 26 Bray, F, Transitions in human development and the global cancer burden. Wild, CP, Stewart, B, (eds.) World Cancer Report 2014, 2014, International Agency for Research on Cancer, Lyon, France.
27. 27 Porter, P, Westernizing women's risks? Breast cancer in lower income countries. N Engl J Med 358 (2008), 213–216.
28. 28 United Nations Development Programme. Human development report. http://hdr.undp.org/en, 2013 (accessed June 8, 2015).
29. 29 Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002), 321–333.
30. 30 DeSantis, C, Howlader, N, Cronin, KA, Jemal, A, Breast cancer incidence rates in U.S. women are no longer declining. Cancer Epidemiol Biomarkers Prev 20 (2011), 733–739.
31. 31 Burstein, HJ, Prestrud, AA, Seidenfeld, J, et al. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28 (2010), 3784–3796.
32. 32 Peto, R, Davies, C, Godwin, J, et al., for the Early Breast Cancer Trialists’ Collobrative Group (EBCTCG). Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials. Lancet 379 (2012), 432–444.
33. 33 Gustafsson, L, Ponten, J, Bergstrom, R, Adami, HO, International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer 71 (1997), 159–165.
34. 34 Wabinga, HR, Nambooze, S, Amulen, PM, Okello, C, Mbus, L, Parkin, DM, Trends in the incidence of cancer in Kampala, Uganda 1991–2010. Int J Cancer 135 (2014), 432–439.
35. 35 Chokunonga, E, Borok, MZ, Chirenje, ZM, Nyakabau, AM, Parkin, DM, Trends in the incidence of cancer in the black population of Harare, Zimbabwe 1991–2010. Int J Cancer 133 (2013), 721–729.
36. 36 Bray, F, Lortet-Tieulent, J, Znaor, A, Brotons, M, Poljak, M, Arbyn, M, Patterns and trends in human papillomavirus-related diseases in Central and Eastern Europe and Central Asia. Vaccine 31:suppl 7 (2013), H32–H45.
37. 37 Knaul, FM, Bhadelia, A, Arreola-Ornelas, H, et al. Women's reproductive health in transition: the overlapping challenge of breast and cervical cancer. Cancer Control 11 (2014), 50–59.
38. 38 Singh, G, Azuine, RE, Siahpush, M, Global inequalities in cervical cancer incidence and mortality are linked to deprivation, low socioeconomic status, and human development. Int J MCH AIDS 1 (2012), 17–30.
39. 39 Coleman, MP, Forman, D, Bryant, H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377 (2011), 127–138.
40. 40 Walters, S, Benitez-Majano, S, Muller, P, et al. Is England closing the international gap in cancer survival?. Br J Cancer 113 (2015), 848–860.
41. 41 De Angelis, R, Sant, M, Coleman, M, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5—a population-based study. Lancet Oncol 15 (2014), 23–34.
42. 42 Cherny, NI, Eniu, A, Sullivan, R, et al. ESMO European Consortium Study on the availsbility of anti-neoplastic medicines across Europe. Ann Oncol, 25(suppl 4), 2014, iv39 (abstr 114IN).
43. 43 Iqbal, J, Ginsburg, O, Rochon, P, Sun, P, Narod, S, Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA 313 (2015), 165–173.
44. 44 Tao, L, Gomez, SL, Keegan, THM, Kurian, AW, Clarke, OA, Breast cancer mortality in African-American and non-Hispanic white women by molecular subtype and stage at diagnosis: a population-based study. Cancer Epidemiol Biomarkers Prev 24 (2015), 1039–1045.
45. 45 Bigby, J, Holmes, MD, Disparities across the breast cancer continuum. Cancer Causes Control 16 (2005), 35–44.
46. 46 Chlebowski, RT, Chen, Z, Anderson, GL, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst 97 (2005), 439–448.
47. 47 Newmann, SJ, Garner, EO, Social inequities along the cervical cancer continuum: a structured review. Cancer Causes Control 16 (2005), 63–70.
48. 48 Newman, LA, Griffith, KA, Jatoi, I, Simon, MS, Crowe, JP, Colditz, GA, Metaanalysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. J Clin Oncol 24 (2006), 1342–1349.
49. 49 Carey, LA, Perou, CM, Livasy, CA, et al. Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295 (2006), 2492–2501.
50. 50 Maskarinec, G, Sen, C, Koga, K, Conroy, SM, Ethnic differences in breast cancer survival: status and determinants. Womens Health 7 (2011), 677–687.
51. 51 Silber, JH, Rosenbaum, PR, Clark, AS, et al. Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 310 (2013), 389–397.
52. 52 Gomez, SL, Clarke, CA, Shema, SJ, Chang, ET, Keegan, TH, Glaser, SL, Disparities in breast cancer survival among Asian women by ethnicity and immigrant status: a population-based study. Am J Public Health 100 (2010), 861–869.
53. 53 Szczepura, A, Price, C, Gumber, A, Breast and bowel cancer screening uptake patterns over 15 years for U.K. South Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health, 8, 2008, 346.
54. 54 Hanson, K, Montgomery, P, Bakker, D, Conlon, M, Factors influencing mammography participation in Canada: an integrative review of the literature. Curr Oncol 16 (2009), 65–75.
55. 55 Lofters, AK, Moineddin, R, Hwang, SW, Glazier, RH, Predictors of low cervical cancer screening among immigrant women in Ontario, Canada. BMC Womens Health, 11, 2011, 20.
56. 56 Ginsburg, O, Fischer, HD, Shah, BR, et al. A population-based study of ethnicity and breast cancer stage at diagnosis in Ontario. Curr Oncol 22 (2015), 97–104.
57. 57 Maringe, C, Li, R, Mangtani, L, Coleman, MP, Rachet, B, Cancer survival differences between South Asians and non-South Asians of England in 1986–2004, accounting for age at diagnosis and deprivation. Br J Cancer 113 (2015), 173–181.
58. 58 Moore, S, Antoni, S, Colquhoun, A, et al. Cancer incidence in indigenous people in Australia, New Zealand, Canada and the USA: a comparative population-based study. Lancet Oncol 16 (2015), 1483–1492.
59. 59 Vasilevska, M, Ross, SA, Gesink, D, Fisman, DN, Relative risk of cervical cancer in indigenous women in Australia, Canada, New Zealand, and the United States: a systematic review and meta-analysis. J Public Health Policy 33 (2012), 148–164.
60. 60 Javid, SH, Varghese, TK, Morris, AM, et al. Guideline-concordance cancer care and survival among American Indian/Alaskan Native patients. Cancer 120 (2014), 2183–2190.
61. 61 Valery, PC, Coory, M, Stirling, J, Green, AC, Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study. Lancet 367 (2006), 1842–1848.
62. 62 Shannon, GD, Franco, OH, Powles, J, Leng, Y, Pashayan, N, Cervical cancer in Indigenous women: the case of Australia. Maturitas 70 (2011), 234–245.
63. 63 Moore, SP, Green, AC, Bray, F, et al. Survival disparities in Australia: an analysis of patterns of care and comorbidities among indigenous and non-indigenous cancer patients. BMC Cancer, 14, 2014, 517.
64. 64 Moore, SP, Forman, D, Pineros, M, Fernandez, SM, de Oliveira Santos, M, Bray, F, Cancer in indigenous people in Latin America and the Caribbean: a review. Cancer Med 3 (2014), 70–80.
65. 65 Bray, F, Ferlay, J, Laversanne, M, et al. Cancer incidence in five continents: inclusion criteria, highlights from volume X, and the global status of cancer registration. Int J Cancer 137 (2015), 2060–2071.
66. 66 Leong, SPL, Shen, Z-Z, Liu, T-J, et al. Is breast cancer the same disease in Asian and Western women?. World J Surgery 34 (2010), 2308–2324.
67. 67 Abdulrahman, GO Jr, Rahman, GA, Epidemiology of breast cancer in Europe and Africa. J Cancer Epidemiol, 2012, 2012, 915610.
68. 68 Adesunkanmi, ARK, Lawal, OO, Adelusola, KA, Durosimi, MA, The severity, outcome and challenges of breast cancer in Nigeria. Breast 15 (2006), 399–409.
69. 69 Rambau, PF, Chalya, PL, Manyama, MM, Jackson, KL, Pathological features of breast cancer seen in northwestern Tanzania: a nine years retrospective study. BMC Res Notes 4 (2011), 214–219.
70. 70 Kantelhardt, EJ, Zerche, P, Mathewos, A, et al. Breast cancer survival in Ethiopia: a cohort study of 1,070 women. Int J Cancer 135 (2014), 702–709.
71. 71 Bewtra, C, Clinicopathologic features of female breast cancer in Kumasi, Ghana. Int J Cancer Res 6 (2010), 154–160.
72. 72 Abbass, F, Bennis, S, Znati, K, et al. Epidemiological and biologic profile of breast cancer in Fez-Boulemane, Morocco. East Mediterr Health J 17 (2011), 930–936.
73. 73 Othieno-Abinya, NA, Wanzala, P, Omollo, R, et al. Comparative study of breast cancer risk factors at Kenyatta National Hospital and the Nairobi Hospital. Afr J Cancer 7 (2015), 41–46.
74. 74 CIA World Factbook. https://www.cia.gov/library/publications/the-world-factbook/ (accessed Aug 2, 2015).
75. 75 Plummer, M, Peto, J, Franceschi, S, on behalf of the International Collaboration of Epidemiological Studies of Cervical Cancer. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer 130 (2012), 2638–2644.
76. 76 UNAIDS. HPV, HIV and cervical cancer: leveraging synergies to save women's lives. http://www.unaids.org/en/resources/documents/2016/HPV-HIV-cervical-cancer, July 20, 2016 (accessed Sept 30, 2016).
77. 77 Centers for Disease Control and Prevention. HPV-associated cancer diagnosis by age. http://www.cdc.gov/cancer/hpv/statistics/age.htm (accessed Aug 8, 2015).
78. 78 Sreedevi, A, Javed, R, Dinesh, A, Epidemiology of cervical cancer with special focus on India. Int J Womens Health 7 (2015), 405–414.
79. 79 van Bogaert, LJ, Age at diagnosis of preinvasive and invasive cervical neoplasia in South Africa HIV-positive versus HIV-negative women. Int J Gynecol Cancer 21 (2011), 363–366.
80. 80 Bazile, J, Rigodon, J, Berman, L, Boulanger, VM, Maistrellis, E, Kausiwa, P, Yamin, AE, Intergenerational impacts of maternal mortality: qualitative findings from rural Malawi. Reprod Health, 12(supp 1), 2015, S1.
81. 81 Langer, A, Meleis, A, Knaul, FM, et al. Women and health: the key for sustainable development. Lancet 386 (2015), 1165–1210.
82. 82 Ginsburg, O, Badwe, R, Boyle, P, et al. Changing global policy to deliver safe, equitable, and affordable care for women's cancers. Lancet, 2016 published online Nov 1. http://dx.doi.org/10.1016/S0140-6736(16)31393-9.
83. 83 Braitstein, P, Ayaya, S, Nyandiko, WM, et al. Nutritional status of orphaned and separated children and adolescents living in community and institutional environments in Uasin Gishu County, Kenya. PLoS One, 8, 2013, e70054.
84. 84 Moucheraud, C, Worku, A, Molla, M, Finlay, JE, Leaning, J, Yamin, AE, Consequences of maternal mortality on infant and child survival: a 25-year longitudinal analysis in Butajira Ethiopia (1987–2011). Reprod Health, 12(suppl 1), 2015, S4.
85. 85 Stenberg, K, Axelson, H, Sheehan, P, et al., the Study Group for the Global Investment Framework for Women's Children's Health. Advancing social and economic development by investing in women's and children's health: a new Global Investment Framework. Lancet 383 (2014), 1333–1354.
86. 86 International Labour Organization. Global employment trends for women, 2008, International Labour Organization, Geneva.
87. 87 Jamison, DT, Summers, LH, Alleyne, G, et al. Global health 2035: a world converging within a generation. Lancet 382 (2013), 1898–1955.
88. 88 Hausman, R, Tyson, LD, Zahidi, S, The global gender gap report 2012, 2012, World Economic Forum, Geneva.
89. 89 Bloom, DE, Cafiero, ET, Jané-Llopis, E, et al. The global economic burden of non-communicable diseases, 2011, World Economic Forum, Geneva.
90. 90 Beaulieu, N, Bloom, D, Bloom, R, Stein, R, Breakaway: the global burden of cancer-challenges and opportunities. Economist Intelligence Unit, 2009, The Economist, London.
91. 91 John, RM, Ross, H, The global economic costs of cancer. Livestrong and the American Cancer Society. http://www.cancer.org/acs/groups/content/@internationalaffairs/documents/document/acspc-026203.pdf (accessed Nov 23, 2015).
92. 92 WHO. WHO guide to identifying the economic consequences of disease and injury, 2009, World Health Organization, Geneva.
93. 93 Pakseresht, S, Ingle, GK, Garg, S, Singh, MM, Expenditure audit of women with breast cancer in a tertiary care hospital of Delhi. Indian J Cancer 48 (2011), 428–437.
94. 94 Woodward, M, Kimman, M, Jan, S, Mejri, AA, The economic cost of cancer to patients and their families in Southeast Asia. Asia Pac J Clin Oncol, 10, 2014, 43.
95. 95 Kimman, M, Jan, S, Yip, CH, et al., for the ACTION Study Group. Catastrophic health expenditure and 12-month mortality associated with cancer in Southeast Asia: results from a longitudinal study in eight countries. BMC Med, 13, 2015, 190.
96. 96 Hailu, A, Mariam, DH, Patient side cost and its predictors for cervical cancer in Ethiopia: a cross sectional hospital based study. BMC Cancer, 13, 2013, 69.
97. 97 Hoang Lan, N, Laohasiriwong, W, Stewart, JF, Tung, ND, Coyte, PC, Cost of treatment for breast cancer in central Vietnam. Glob Health Action, 6, 2013, 18872.
98. 98 Zaidi, AA, Ansari, TZ, Aziz, K, The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital. Int J Equity Health, 11, 2012, 60.
99. 99 Zeeshan, Y, Muhammad, Y, Ahson, M, A Pilot study the socio-economic impact of cancer on patients and their families in a developing country. Eur J Med Res, 15, 2010, 197.
100. 100 Alliance for Cervical Cancer Prevention. The case for investing in cervical cancer prevention. Cervical Cancer Prevention Issues in Depth, no. 3, 2004, Alliance for Cervical Cancer Prevention, Seattle.
101. 101 Arrossi, S, Matos, E, Zengarini, N, Roth, B, Sankaranayananan, R, Parkin, M, The socio-economic impact of cervical cancer on patients and their families in Argentina, and its influence on radiotherapy compliance. Results from a cross-sectional study. Gynecol Oncol 105 (2007), 335–340.
102. 102 Berraho, M, Najdi, A, Mathoulin-Pelissier, S, Salamon, R, Nejjari, C, Direct costs of cervical cancer management in Morocco. Asian Pac J Cancer Prev 13 (2012), 3159–3163.
103. 103 Boncz, I, Endrei, D, Agoston, I, et al. Annual health insurance cost of breast cancer treatment in Hungary. Value Health, 17, 2014, A735.
104. 104 Goldhaber-Fiebert, JD, Goldie, SJ, Estimating the cost of cervical cancer screening in five developing countries. Cost Eff Resour Alloc, 4, 2006, 13.
105. 105 Davari, M, Yazdanpanah, F, Aslani, A, Hosseini, M, Nazari, AR, Mokarian, F, The direct medical costs of breast cancer in Iran: analyzing the patient's level data from a cancer specific hospital in Isfahan. Int J Prev Med 4 (2013), 748–754.
106. 106 Boutayeb, S, Boutayeb, A, Ahbeddou, N, et al. Estimation of the cost of treatment by chemotherapy for early breast cancer in Morocco. Cost Eff Resour Alloc, 8, 2010, 16.
107. 107 Gelband, H, Sankaranarayanan, R, Gaureau, C, et al. Costs, affordability, and feasibility of an essential package of cancer control interventions in low-income and middle-income countries: key messages from Disease Control Priorities, 3rd edition. Lancet 387 (2016), 2133–2144.
108. 108 Bustreo, F, Knaul, FM, Bhadelia, A, Beard, J, Araujo de Carvalho, I, Women's health beyond reproduction: meeting the challenges. Bull World Health Organ, 90, 2012, 478 78A.
109. 109 Atun, R, Jaffar, S, Nishtar, S, et al. Improving responsiveness of health systems to non-communicable diseases. Lancet 381 (2013), 690–697.
110. 110 WHO. Every Woman Every Child Global Strategy 2.0. http://www.who.int/life-course/partners/global-strategy/en/ (accessed April 11, 2016).
111. 111 UN Secretary General's Message. World Cancer Day 4 February, 2016. http://www.un.org/en/events/cancerday/sgmessage.shtml (accessed April 11, 2016).